Skip to main content
Clinical Trials/JPRN-jRCTs032180392
JPRN-jRCTs032180392
Recruiting
Phase 2

Focal cryotherapy for prostate cancer, a prospective study

Kimura Takahiro0 sites60 target enrollmentMarch 20, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
Kimura Takahiro
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 20, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Kimura Takahiro

Eligibility Criteria

Inclusion Criteria

  • 1, Primary prostate cancer
  • 1\) Gleason score, under 7
  • 2\) PSA, under 20 ng/ml
  • 3\) Patient who has targeted region with PIRADS score 3 or more by MRI
  • 4\) Clinically significant cancer proven by MRI/US fusion biopsy and MRI imaging
  • 5\) Gleason score of cancer(s) detected by transperineal saturation biopsy except for targeted lesion is 6 or lower
  • 6\) No positive findings except for targeted lesion by MRI
  • 7\) Clinical T stage, under T3a
  • 8\) PS 0,1 .
  • 2, Local recurrence prostate cancer after definitive radiotherapy

Exclusion Criteria

  • 1\) Patient with active multiple cancers
  • 2\) Patient having uncontrolled hypertension, diabetes and ischemic cardiac disease
  • 3\) Patient using steroidal agents
  • 4\) Patient having hormone therapy within 3 months from consented day.
  • 5\) Patient to whom participating physicians judged to be inappropriate for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials